{"doc_id": "paper1", "text": "A systematic review of antiretroviral therapy adherence in Sub-Saharan Africa.\n42 studies with 15,000 HIV-positive patients were included.\nAdherence to ART was 78% (95% CI 72-84%).\nBarriers included stigma and distance to clinics.\nMethods:\nWe searched PubMed, Scopus, and Web of Science from January 1990 to March 2024. \nAfter removing duplicates, 1,240 records were screened, and 137 full-text articles were assessed for eligibility.\nSeventy articles were excluded due to incomplete data, leaving 67 studies for analysis. \nTwo reviewers independently screened all titles and abstracts.\n\nResults:\nA total of 67 studies (n = 88,345 participants) from 25 countries were included. \nThe largest sample sizes were from China (n = 35,812), the United States (n = 10,437), and Germany (n = 7,670). \nOther notable sample sizes included Bangladesh (n = 2,909), Ethiopia (n = 2,033), Egypt (n = 3,204), and Vietnam (n = 2,945).\nFourteen were randomized controlled trials, ten cohort studies, and three case-control studies.\n", "spans": [{"start": 2, "end": 19, "label": "REVIEW_TYPE", "text": "systematic review"}, {"start": 59, "end": 77, "label": "REGION", "text": "Sub-Saharan Africa"}, {"start": 79, "end": 89, "label": "N_STUDIES", "text": "42 studies"}, {"start": 95, "end": 123, "label": "RISK_GROUP", "text": "15,000 HIV-positive patients"}, {"start": 160, "end": 163, "label": "PERCENT", "text": "78%"}, {"start": 165, "end": 171, "label": "CI", "text": "95% CI"}, {"start": 181, "end": 222, "label": "SEARCH_TERMS", "text": "Barriers included stigma and distance to "}, {"start": 252, "end": 258, "label": "DATABASE", "text": "PubMed"}, {"start": 260, "end": 266, "label": "DATABASE", "text": "Scopus"}, {"start": 272, "end": 286, "label": "DATABASE", "text": "Web of Science"}, {"start": 292, "end": 318, "label": "DATE_OF_LAST_LITERATURE_SEARCH", "text": "January 1990 to March 2024"}, {"start": 348, "end": 361, "label": "N_STUDIES", "text": "1,240 records"}, {"start": 381, "end": 403, "label": "N_STUDIES", "text": "137 full-text articles"}, {"start": 498, "end": 508, "label": "N_STUDIES", "text": "67 studies"}, {"start": 599, "end": 618, "label": "N_STUDIES", "text": "total of 67 studies"}, {"start": 620, "end": 630, "label": "SAMPLE_SIZE", "text": "n = 88,345"}, {"start": 650, "end": 662, "label": "COUNTRY", "text": "25 countries"}, {"start": 714, "end": 719, "label": "COUNTRY", "text": "China"}, {"start": 721, "end": 731, "label": "SAMPLE_SIZE", "text": "n = 35,812"}, {"start": 738, "end": 751, "label": "COUNTRY", "text": "United States"}, {"start": 753, "end": 763, "label": "SAMPLE_SIZE", "text": "n = 10,437"}, {"start": 770, "end": 777, "label": "COUNTRY", "text": "Germany"}, {"start": 779, "end": 788, "label": "SAMPLE_SIZE", "text": "n = 7,670"}, {"start": 828, "end": 838, "label": "COUNTRY", "text": "Bangladesh"}, {"start": 840, "end": 849, "label": "SAMPLE_SIZE", "text": "n = 2,909"}, {"start": 852, "end": 860, "label": "COUNTRY", "text": "Ethiopia"}, {"start": 862, "end": 871, "label": "SAMPLE_SIZE", "text": "n = 2,033"}, {"start": 874, "end": 879, "label": "COUNTRY", "text": "Egypt"}, {"start": 881, "end": 890, "label": "SAMPLE_SIZE", "text": "n = 3,204"}, {"start": 897, "end": 904, "label": "COUNTRY", "text": "Vietnam"}, {"start": 906, "end": 915, "label": "SAMPLE_SIZE", "text": "n = 2,945"}, {"start": 932, "end": 960, "label": "STUDY_DESIGN", "text": "randomized controlled trials"}, {"start": 966, "end": 980, "label": "STUDY_DESIGN", "text": "cohort studies"}, {"start": 992, "end": 1004, "label": "STUDY_DESIGN", "text": "case-control"}], "metadata": {"filepath": "infectious_disease_papers/paper1.txt", "file_size": 1014, "processing_time": "2025-12-18T00:00:48.166263", "hash": "15c82ac190e922a6da5864c93d3736d2", "total_labels_found": 12}, "stats": {"rule_based_entities": 24, "llm_entities": 27, "total_entities": 34, "rule_stats": {"REVIEW_TYPE": 1, "STUDY_DESIGN": 1, "N_STUDIES": 3, "DATABASE": 3, "SEARCH_TERMS": 1, "PATHOGEN": 1, "RISK_GROUP": 1, "PERIOD": 1, "COUNTRY": 3, "REGION": 1, "SAMPLE_SIZE": 8, "CI": 1}, "label_distribution": {"REVIEW_TYPE": 1, "REGION": 1, "N_STUDIES": 5, "RISK_GROUP": 1, "PERCENT": 1, "CI": 1, "SEARCH_TERMS": 1, "DATABASE": 3, "DATE_OF_LAST_LITERATURE_SEARCH": 1, "SAMPLE_SIZE": 8, "COUNTRY": 8, "STUDY_DESIGN": 3}, "unique_labels": ["REVIEW_TYPE", "REGION", "N_STUDIES", "RISK_GROUP", "PERCENT", "CI", "SEARCH_TERMS", "DATABASE", "DATE_OF_LAST_LITERATURE_SEARCH", "SAMPLE_SIZE", "COUNTRY", "STUDY_DESIGN"]}}
{"doc_id": "paper2", "text": "Meta-analysis of MDR-TB treatment outcomes in high-burden countries.\n28 studies from India, China, and South Africa.\nTreatment success rate was 65% for MDR-TB vs 88% for drug-sensitive TB.", "spans": [{"start": 0, "end": 13, "label": "REVIEW_TYPE", "text": "Meta-analysis"}, {"start": 17, "end": 23, "label": "PATHOGEN", "text": "MDR-TB"}, {"start": 69, "end": 79, "label": "N_STUDIES", "text": "28 studies"}, {"start": 85, "end": 90, "label": "COUNTRY", "text": "India"}, {"start": 92, "end": 97, "label": "COUNTRY", "text": "China"}, {"start": 103, "end": 115, "label": "COUNTRY", "text": "South Africa"}, {"start": 144, "end": 147, "label": "PERCENT", "text": "65%"}, {"start": 156, "end": 158, "label": "PATHOGEN", "text": "TB"}, {"start": 162, "end": 165, "label": "PERCENT", "text": "88%"}, {"start": 185, "end": 187, "label": "PATHOGEN", "text": "TB"}], "metadata": {"filepath": "infectious_disease_papers/paper2.txt", "file_size": 188, "processing_time": "2025-12-18T00:00:51.693245", "hash": "b704ab89ed52a283729490c1cb2714ef", "total_labels_found": 5}, "stats": {"rule_based_entities": 8, "llm_entities": 7, "total_entities": 10, "rule_stats": {"REVIEW_TYPE": 2, "STUDY_DESIGN": 1, "N_STUDIES": 4, "DATABASE": 3, "SEARCH_TERMS": 1, "PATHOGEN": 4, "RISK_GROUP": 1, "PERIOD": 1, "COUNTRY": 6, "REGION": 1, "SAMPLE_SIZE": 8, "CI": 1, "ANALYSIS": 1}, "label_distribution": {"REVIEW_TYPE": 1, "PATHOGEN": 3, "N_STUDIES": 1, "COUNTRY": 3, "PERCENT": 2}, "unique_labels": ["REVIEW_TYPE", "PATHOGEN", "N_STUDIES", "COUNTRY", "PERCENT"]}}
{"doc_id": "paper3", "text": "Systematic review of insecticide-treated bed net distribution.\nCoverage increased from 45% to 82% after community-based programs.\nMalaria incidence decreased by 67% (RR 0.33, 95% CI 0.25-0.44).", "spans": [{"start": 0, "end": 17, "label": "REVIEW_TYPE", "text": "Systematic review"}, {"start": 21, "end": 61, "label": "PROGRAM", "text": "insecticide-treated bed net distribution"}, {"start": 63, "end": 97, "label": "COVERAGE", "text": "Coverage increased from 45% to 82%"}, {"start": 98, "end": 128, "label": "PROGRAM", "text": "after community-based programs"}, {"start": 130, "end": 137, "label": "PATHOGEN", "text": "Malaria"}, {"start": 166, "end": 168, "label": "EFFECT_MEASURE", "text": "RR"}, {"start": 175, "end": 181, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper3.txt", "file_size": 193, "processing_time": "2025-12-18T00:00:55.566651", "hash": "e06836707d0ee7ee126060ed987d2bc8", "total_labels_found": 6}, "stats": {"rule_based_entities": 5, "llm_entities": 7, "total_entities": 7, "rule_stats": {"REVIEW_TYPE": 3, "STUDY_DESIGN": 1, "N_STUDIES": 4, "DATABASE": 3, "SEARCH_TERMS": 1, "PATHOGEN": 5, "RISK_GROUP": 1, "PERIOD": 1, "COUNTRY": 6, "REGION": 1, "SAMPLE_SIZE": 8, "CI": 2, "ANALYSIS": 1, "CONDITION": 1, "LOGISTICS": 1, "EFFECT_MEASURE": 1}, "label_distribution": {"REVIEW_TYPE": 1, "PROGRAM": 2, "COVERAGE": 1, "PATHOGEN": 1, "EFFECT_MEASURE": 1, "CI": 1}, "unique_labels": ["REVIEW_TYPE", "PROGRAM", "COVERAGE", "PATHOGEN", "EFFECT_MEASURE", "CI"]}}
